ARCA Hero Image
rNAPc2 as a potential treatment for severe COVID-19
ASPEN-COVID-19
Phase 2b Clinical Trial
rNAPc2 as a potential treatment for severe COVID-19
ASPEN-COVID-19
Phase 2b Clinical Trial
hex-clinical-trial

Status

ASPEN-COVID-19 began enrolling patients in Dec 2020

Topline clinical trial data anticipated Q3 2021

U.S. FDA Fast Track designation granted Nov 2020